HAE Meeting - BORING

Quote

anonymous

Guest
Hello Management,
Any idea why the lack of excitement at the HAE meeting?

What did you honestly expect?

- Could it be the backpedaling / lying you pulled with the loss Kcentra contracts and the IC payout?
- Could it be the IC crap and lying you did with the Hargarda launch IC?
- Could it be the Specialty sales force have been contacted by recruiters for Kalvista and the SALARY range is $160-$175k and 50-70k commissions?
CSL management has NO credibility and the standard reply is " if you don't like it - then leave".
 












This was only sent by email, not a word in a press release, „At our Research and Development investor briefing held this Tuesday the 22nd of October, we announced that we received a Complete Response Letter from the FDA in regards to our submission for Garadacimab.
The FDA has requested more information in relation to our manufacturing process. There were no safety or efficacy issued identified.
We are currently working with the agency to address outstanding questions and expect to refile soon and anticipate approval in the first half of 2025.
 






Corr
anonymous said:
Hello Management,
Any idea why the lack of excitement at the HAE meeting?

What did you honestly expect?

- Could it be the backpedaling / lying you pulled with the loss Kcentra contracts and the IC payout?
- Could it be the IC crap and lying you did with the Hargarda launch IC?
- Could it be the Specialty sales force have been contacted by recruiters for Kalvista and the SALARY range is $160-$175k and 50-70k commissions?
CSL management has NO credibility and the standard reply is " if you don't like it - then leave".Correct.
Click to expand...
 






Top Bottom
Back
Quote